(Q47567371)

4 February 2018

1 reference

24 March 2019

1 reference

1 reference

Nutritional Deficiencies and Clinical Correlates in First-Episode Psychosis: A Systematic Review and Meta-analysis. (English)

1 reference

4 February 2018

1 reference

24 March 2019

1 reference

24 March 2019

1 reference

24 March 2019

1 reference

1 reference

1 reference

Scott B Teasdale

4

0 references

Joseph Firth

Joseph Firth

1

0 references

Michael Berk

Michael Berk

7

0 references

Philip B. Ward

Philip B Ward

6

0 references

Davy Vancampfort

5

Davy Vancampfort

1 reference

4 February 2018

Rebekah Carney

2

1 reference

4 February 2018

Brendon Stubbs

3

1 reference

4 February 2018

Jerome Sarris

8

1 reference

4 February 2018

language of work or name

English

0 references

publication date

30 November 2017

1 reference

4 February 2018

17 October 2018

1 reference

24 March 2019

Schizophrenia Bulletin

2 references

4 February 2018

Creative Commons Attribution 4.0 International

24 March 2019

1 reference

on focus list of Wikimedia project

24 March 2019

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

Nutritional medicine as mainstream in psychiatry.

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

International Society for Nutritional Psychiatry Research consensus position statement: nutritional medicine in modern psychiatry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

Dietary pattern and depressive symptoms in middle age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

Association of Western and traditional diets with depression and anxiety in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

Relationship between diet and mental health in children and adolescents: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

Diet, exercise and the metabolic syndrome in schizophrenia: A cross-sectional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

The dietary pattern of patients with schizophrenia: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

Folate, homocysteine, interleukin-6, and tumor necrosis factor alfa levels, but not the methylenetetrahydrofolate reductase C677T polymorphism, are risk factors for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

Plasma homocysteine in schizophrenia: determinants and clinical correlations in Tunisian patients free from antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

Folate, homocysteine, and negative symptoms in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

The effects of vitamin and mineral supplementation on symptoms of schizophrenia: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

Folate and homocysteine metabolism: therapeutic targets in cardiovascular and neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

Meta-analysis of oxidative stress in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

Is it time to trial vitamin D supplements for the prevention of schizophrenia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

Low maternal vitamin D as a risk factor for schizophrenia: a pilot study using banked sera.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

Vitamin D supplementation during the first year of life and risk of schizophrenia: a Finnish birth cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

Clinical correlates of vitamin D deficiency in established psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

Correlates of vitamin D in psychotic disorders: A comprehensive systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

Comparative Study on Serum Levels of 10 Trace Elements in Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

Zinc in depression: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

Dietary selenium and major depression: a nested case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

Serum folate levels in schizophrenia: A meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

Serum vitamin D levels in relation to schizophrenia: a systematic review and meta-analysis of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

A nutrition intervention is effective in improving dietary components linked to cardiometabolic risk in youth with first-episode psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

Progressive brain change in schizophrenia: a prospective longitudinal study of first-episode schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

Cardiovascular risk in a first-episode psychosis sample: a 'critical period' for prevention?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

Antipsychotic-induced weight gain in first-episode psychosis patients: a meta-analysis of differential effects of antipsychotic medications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

Essential elements of an early intervention service for psychosis: the opinions of expert clinicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

The Lambeth Early Onset (LEO) Team: randomised controlled trial of the effectiveness of specialised care for early psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

Is abnormal glucose tolerance in antipsychotic-naive patients with nonaffective psychosis confounded by poor health habits?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

Reduced urinary excretion of homocysteine could be the reason of elevated plasma homocysteine in patients with psychiatric illnesses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

The positive and negative syndrome scale (PANSS) for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

Serum levels of BDNF, folate and homocysteine: in relation to hippocampal volume and psychopathology in drug naïve, first episode schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

Effects of second-generation antipsychotics on selected markers of one-carbon metabolism and metabolic syndrome components in first-episode schizophrenia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

Reduced folic acid, vitamin B12 and docosahexaenoic acid and increased homocysteine and cortisol in never-medicated schizophrenia patients: implications for altered one-carbon metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

Elevated homocysteine level in first-episode schizophrenia patients--the relevance of family history of schizophrenia and lifetime diagnosis of cannabis abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

Vitamin D status in psychotic disorder patients and healthy controls--The influence of ethnic background

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

Association Between Vitamin D Status and Schizophrenia: A First Psychotic Episode Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

Relationship of low vitamin D status with positive, negative and cognitive symptom domains in people with first-episode schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

Association between serum levels of bioavailable vitamin D and negative symptoms in first-episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

Oxidative stress, α-tocopherol, ascorbic acid and reduced glutathione status in schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

Supplementation of vitamin C with atypical antipsychotics reduces oxidative stress and improves the outcome of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

Association of Single Nucleotide Polymorphisms in Catechol-O-Methyltransferase and Serine-Threonine Protein Kinase Genes in the Pakistani Schizophrenic Population: A Study with Special Emphasis on Cannabis and Smokeless Tobacco

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

The influence of some antipsychotics on erythrocyte magnesium and plasma magnesium, calcium, copper and zinc in patients with paranoid schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

Developmental vitamin D deficiency and risk of schizophrenia: a 10-year update

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

Vitamin D, cognition, and dementia: A systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

Vitamin D and metabolic health with special reference to the effect of vitamin D on serum lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

Serum vitamin D and hippocampal gray matter volume in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

The epidemiology of global micronutrient deficiencies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

One-carbon metabolism and schizophrenia: current challenges and future directions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

Randomized multicenter investigation of folate plus vitamin B12 supplementation in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

Dietary intake of schizophrenic patients in Nithsdale, Scotland: case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

Vitamin D and mental health - the scrutiny of science delivers a sober message.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

Vitamin D supplements and cancer incidence and mortality: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

N-acetyl cysteine as a glutathione precursor for schizophrenia--a double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

Adjunctive Taurine in First-Episode Psychosis: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

Vitamin D and mortality: meta-analysis of individual participant data from a large consortium of cohort studies from Europe and the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

Design and rationale of a 16-week adjunctive randomized placebo-controlled trial of mitochondrial agents for the treatment of bipolar depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

The history of childhood trauma is associated with lipid disturbances and blood pressure in adult first-episode schizophrenia patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

Vitamin D deficiency in first episode psychosis: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

High levels of vitamin D in relation to reduced risk of schizophrenia with elevated C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

First-episode psychosis is associated with oxidative stress: Effects of short-term antipsychotic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

CSF sub-compartments in relation to plasma osmolality in healthy controls and in patients with first episode schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

Biochemical, physiological and clinical effects of l-methylfolate in schizophrenia: a randomized controlled trial

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6192507

1, 25-dihydroxyvitamin D3, a potential role player in the development of thyroid disorders in schizophrenics

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6192507

Solving a weighty problem: systematic review and meta-analysis of nutrition interventions in severe mental illness

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6192507

A comparison of the nutrient intake of a community-dwelling first-episode psychosis cohort, aged 19-64 years, with data from the UK population

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6192507

Serum trace element differences between Schizophrenia patients and controls in the Han Chinese population

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6192507

Serum copeptin and its diagnostic performance in schizophrenia.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6192507

Status of plasma nitric oxide and non-enzymatic antioxidants before and after antipsychotic treatment in Nigerian patients with schizophrenia

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6192507

Essential trace metals and heavy metals in newly diagnosed schizophrenic patients and those on anti-psychotic medication

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6192507

Vitamin D deficiency: a global perspective

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6192507

Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6192507

Oral 5'-methyltetrahydrofolic acid in senile organic mental disorders with depression: results of a double-blind multicenter study.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6192507

Folate supplementation in schizophrenia: A possible role for MTHFR genotype

2 November 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBX162

Smoking habits and plasma lipid peroxide and vitamin E levels in never-treated first-episode patients with schizophrenia

21 January 2018

1 reference

12 December 2020

Serum folate and cardiovascular disease mortality among US men and women

1 reference

12 December 2020

Life expectancy among persons with schizophrenia or bipolar affective disorder

1 reference

12 December 2020

Homocysteine and cognition in first-episode psychosis patients

1 reference

12 December 2020

Vitamin B12 and the risk of schizophrenia: A meta-analysis

1 reference

12 December 2020

Identifiers

DOI

10.1093/SCHBUL/SBX162

1 reference

4 February 2018

release_hu4nyvby2zeulkrzn4wca7sgei

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hu4nyvby2zeulkrzn4wca7sgei

24 November 2022

mapped directly with Wikidata item

0 references

1 reference

4 February 2018